NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

Core Points - NanoViricides, Inc. has completed a securities purchase agreement with a healthcare institutional investor [1] - The agreement involves the purchase of 3,571,429 shares of common stock at a price of $1.68 per share [1] - The gross proceeds from this offering amount to approximately $6 million before expenses [1]